MMIT & The Dedham Group Unite to Smooth Access to Therapy
April 27, 2021 07:00 ET
|
Managed Markets Insight & Technology, LLC
Yardley, PA, April 27, 2021 (GLOBE NEWSWIRE) -- Managed Markets Insight & Technology, LLC. (MMIT), the trusted go-to- market partner solely focused on solving the “what and why” of market...
Syneos Health Communications Bolsters Value, Access and Public Affairs Offerings with Key Senior Hires
February 23, 2021 09:51 ET
|
Syneos Health, Inc.
MORRISVILLE, N.C., Feb. 23, 2021 (GLOBE NEWSWIRE) -- Syneos Health Communications – the portfolio of Syneos Health® agencies designed to deliver insights-driven integrated communications spanning...
Regenerative Medicine in Pharma 2020 - Opportunities, Challenges, and Unmet Needs
December 23, 2020 02:33 ET
|
Research and Markets
Dublin, Dec. 23, 2020 (GLOBE NEWSWIRE) -- The "Regenerative Medicine in Pharma - Thematic Research" report has been added to ResearchAndMarkets.com's offering. Regenerative medicine is a...
Real Endpoints Launches the First Turn-Key Platform for Value-Based Contracting
December 09, 2020 10:45 ET
|
Real Endpoints
The RE Marketplace established with four founding health plans representing nearly 2.5 million lives. Each plan and its beneficiaries get immediate access to contracts for all biotech drugs in the...
Real Endpoints Strengthens and Broadens Access Capabilities and Reach with the Hiring of Key Executive
November 10, 2020 14:30 ET
|
Real Endpoints
FLORHAM PARK, N.J., Nov. 10, 2020 (GLOBE NEWSWIRE) -- Real Endpoints (RE), a leading boutique life science consultancy focused on market access, today announced it has hired Robert O’Brien as Vice...
Digital therapeutics executive Jeffrey Abraham joins Health Advances, bolstering the firm’s industry-leading digital health practice
August 19, 2020 09:00 ET
|
Health Advances, LLC
NEWTON, Mass., Aug. 19, 2020 (GLOBE NEWSWIRE) -- Health Advances, a global leader in commercial strategy in life sciences, technology, and digital health, today announced the appointment of Jeffrey...
RedHill Biopharma Strengthens Coverage for Talicia® with Preferred Brand Position on Prime Therapeutics NetResults™ National Formulary
April 28, 2020 07:00 ET
|
RedHill Biopharma Ltd.
Talicia® is the first and only FDA-approved rifabutin-based therapy for H. pylori infection, designed as a first-line option to address the high resistance of H. pylori bacteria to standard-of-care...
Real Endpoints’ Susan Raiola Named to 2019 PharmaVoice 100
August 06, 2019 09:00 ET
|
Real Endpoints
MADISON, N.J., Aug. 06, 2019 (GLOBE NEWSWIRE) -- Real Endpoints (RE), an advisory and analytics firm entirely focused on enhancing appropriate access to healthcare innovation, announced today that...
Titan Pharmaceuticals Selects Life Sciences Business Intelligence CRM Innovator, TikaMobile, to Empower its Sales and MSL Teams
February 11, 2019 14:00 ET
|
TikaMobile, Inc.
NEW YORK, Feb. 11, 2019 (GLOBE NEWSWIRE) -- TikaMobile, a premier cloud-based business intelligence CRM provider for the life sciences industry, today announced that Titan Pharmaceuticals, Inc. has...
TikaMobile Announces Business Intelligence CRM Solution for Market Access Teams to Increase Coverage and Pull-through Performance of Sales Teams
December 06, 2018 08:30 ET
|
TikaMobile, Inc.
NEW YORK, Dec. 06, 2018 (GLOBE NEWSWIRE) -- TikaMobile, the premier leader in cloud-based business intelligence and CRM software for the global life sciences industry, announces the latest...